Compounding is the process of creating a medication that's tailored to the needs of an individual patient. Compounded drugs are prepared by licensed compounding pharmacies that comply with government regulations, including administrative requirements and quality standards. andSons is partnering with compounding pharmacies to offer Compounded Semaglutide that uses the same active ingredient as Ozempic® and Wegovy®.

This medication acts like the natural human hormone, GLP-1, to lower blood glucose levels after you’ve eaten a meal. They also block your liver from making glucose and help you feel full for a longer period of time. By regulating your appetite, this treatment may lead to reduced calorie intake and losing weight.

Some people start losing weight in the first 2-4 weeks after starting treatment. It may take up to 8 weeks to see significant weight loss. In clinical studies, the average weight loss was 20% with 77% of patients seeing sustained results for 2 years.*

_{*In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI ≥30, or BMI ≥27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone).}

6 week plan:

• New users: This plan will last patients 6 weeks.
• Returning users: This plan will last patients 2-3 weeks depending on the dose.

11 week plan:

• New users: 6mg Compounded Semaglutide lasts patients 11 weeks.
• Returning users: This plan will last patients 3 weeks at the maintenance dose.